Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP436248.RAXgtMJNcbgEIOEF4mWycyV4uIrEK-UJ77h9-mhuUMzVQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP436248.RAXgtMJNcbgEIOEF4mWycyV4uIrEK-UJ77h9-mhuUMzVQ130_assertion type Assertion NP436248.RAXgtMJNcbgEIOEF4mWycyV4uIrEK-UJ77h9-mhuUMzVQ130_head.
- NP436248.RAXgtMJNcbgEIOEF4mWycyV4uIrEK-UJ77h9-mhuUMzVQ130_assertion description "[The CXCR4 promoter is shown to have a 'tumor-on' and 'liver-off' status in vitro and in vivo, and CXCR4 may prove to be a good candidate TSP for cancer gene therapy approaches for melanoma and breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436248.RAXgtMJNcbgEIOEF4mWycyV4uIrEK-UJ77h9-mhuUMzVQ130_provenance.
- NP436248.RAXgtMJNcbgEIOEF4mWycyV4uIrEK-UJ77h9-mhuUMzVQ130_assertion evidence source_evidence_literature NP436248.RAXgtMJNcbgEIOEF4mWycyV4uIrEK-UJ77h9-mhuUMzVQ130_provenance.
- NP436248.RAXgtMJNcbgEIOEF4mWycyV4uIrEK-UJ77h9-mhuUMzVQ130_assertion SIO_000772 15029227 NP436248.RAXgtMJNcbgEIOEF4mWycyV4uIrEK-UJ77h9-mhuUMzVQ130_provenance.
- NP436248.RAXgtMJNcbgEIOEF4mWycyV4uIrEK-UJ77h9-mhuUMzVQ130_assertion wasDerivedFrom befree-2016 NP436248.RAXgtMJNcbgEIOEF4mWycyV4uIrEK-UJ77h9-mhuUMzVQ130_provenance.
- NP436248.RAXgtMJNcbgEIOEF4mWycyV4uIrEK-UJ77h9-mhuUMzVQ130_assertion wasGeneratedBy ECO_0000203 NP436248.RAXgtMJNcbgEIOEF4mWycyV4uIrEK-UJ77h9-mhuUMzVQ130_provenance.